Charles Craddock

Charlie is the Director of the Blood and Marrow Transplant Unit at the Queen Elizabeth Hospital, Birmingham, Professor of Haemato-oncology at the University of Birmingham and Founder of Cure Leukaemia.

His major areas of clinical interest are the management of myeloid malignancies including Acute Myeloid Leukaemia and Chronic Myeloid Leukaemia and he leads an active clinical trials programme devoted to the design of novel drug and transplant therapies in these diseases.

He is Director of the Centre for Clinical Haematology at the Queen Elizabeth Hospital Birmingham which hosts an internationally competitive early phase clinical trials portfolio.